HCA Healthcare | HCA | Long at $299.00NYSE:HCA Healthcare: P/E of 13x, earnings are forecast to grow 6.01% per year; earnings have grown 10.6% per year over the past 5 years, and trading at good value compared to peers and industry.
From a technical analysis perspective, it dipped to my selected historical simple moving average area a
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
21.5 EUR
5.56 B EUR
68.20 B EUR
174.51 M
About HCA Healthcare, Inc.
Sector
Industry
CEO
Samuel N. Hazen
Website
Headquarters
Nashville
Founded
1968
FIGI
BBG00P1DLY24
HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.
HCA exhibits strong financial health!Technical Analysis
HCA's stock has demonstrated resilience, with a 52-week range between $276.50 and $417.14. The Relative Strength Index (RSI) stands at 58.01, suggesting the stock is neither overbought nor oversold. The Moving Average Convergence Divergence (MACD) is 0.11, indicating a potential
HCA Advances as Tech StumblesHealthcare is the leading sector so far this year, and some traders may see opportunity in hospital operator HCA Healthcare.
Today’s weekly chart considers the all-time high above $410 in October, followed by a substantial pullback. Prices stabilized early this year around $290 (near the low from l
Head & ShouldersThis pattern consists of 2 shoulders that should be in the same ballpark in price but are rarely the exact same price.
The 2 shoulders should be close to the same distance from the head which is a high point between the 2 shoulders.
T1 has just about been met. Sometimes t1 is all we get.
Earnings
HCA Entry, Volume, Target, StopEntry: with price above 294.02
Volume: with volume greater than 4.08M
Target: 313.20 area
Stop: Depending on your risk tolerance; Based on an entry of 294.03, 287.64 gets you 3/1 Reward to Risk Ratio.
This swing trade idea is not trade advice and is strictly based on my ideas and technical analysis
Watchlist 2023-04-25 $SPY $SPOT $FRC $KEY $HCA $SQMAMEX:SPY - was stuck in the +/- 1 range around the high volume node at 412 until it made a sharp dive in the after hours trading. The drop could likely be due to the aftermath of FRC reporting a drop in deposits after the crisis by 100 Billion, which spread fear of contagion to other regions. If SP
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US404119CB3
HCA 21/51Yield to maturity
7.60%
Maturity date
Jul 15, 2051
HCA.GF
Columbia/HCA Healthcare Corp. 7.5% 15-NOV-2095Yield to maturity
7.36%
Maturity date
Nov 15, 2095
HCA5604246
HCA Inc. 4.625% 15-MAR-2052Yield to maturity
7.03%
Maturity date
Mar 15, 2052
HCA5372914
HCA Inc. 4.375% 15-MAR-2042Yield to maturity
6.84%
Maturity date
Mar 15, 2042
HCA4843309
HCA Inc. 5.25% 15-JUN-2049Yield to maturity
6.82%
Maturity date
Jun 15, 2049
HCA5372916
HCA Inc. 4.625% 15-MAR-2052Yield to maturity
6.72%
Maturity date
Mar 15, 2052
HCA4506080
HCA Inc. 5.5% 15-JUN-2047Yield to maturity
6.70%
Maturity date
Jun 15, 2047
HCA5757225
HCA Inc. 6.1% 01-APR-2064Yield to maturity
6.61%
Maturity date
Apr 1, 2064
HCA5581318
HCA Inc. 5.9% 01-JUN-2053Yield to maturity
6.58%
Maturity date
Jun 1, 2053
HCA5868805
HCA Inc. 5.95% 15-SEP-2054Yield to maturity
6.57%
Maturity date
Sep 15, 2054
HCA5757224
HCA Inc. 6.0% 01-APR-2054Yield to maturity
6.54%
Maturity date
Apr 1, 2054
See all 4HCA bonds
Related stocks
Frequently Asked Questions
The current price of 4HCA is 293.0 EUR — it has decreased by −0.61% in the past 24 hours. Watch HCA-HEALTHCARE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EUROTLX exchange HCA-HEALTHCARE stocks are traded under the ticker 4HCA.
4HCA stock has fallen by −1.38% compared to the previous week, the month change is a −2.66% fall, over the last year HCA-HEALTHCARE has showed a 0.034% increase.
We've gathered analysts' opinions on HCA-HEALTHCARE future price: according to them, 4HCA price has a max estimate of 388.25 EUR and a min estimate of 282.77 EUR. Watch 4HCA chart and read a more detailed HCA-HEALTHCARE stock forecast: see what analysts think of HCA-HEALTHCARE and suggest that you do with its stocks.
4HCA reached its all-time high on Oct 21, 2024 with the price of 382.1 EUR, and its all-time low was 57.7 EUR and was reached on Mar 18, 2020. View more price dynamics on 4HCA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4HCA stock is 0.61% volatile and has beta coefficient of 0.28. Track HCA-HEALTHCARE stock price on the chart and check out the list of the most volatile stocks — is HCA-HEALTHCARE there?
Today HCA-HEALTHCARE has the market capitalization of 72.56 B, it has decreased by −3.78% over the last week.
Yes, you can track HCA-HEALTHCARE financials in yearly and quarterly reports right on TradingView.
HCA-HEALTHCARE is going to release the next earnings report on Apr 25, 2025. Keep track of upcoming events with our Earnings Calendar.
4HCA earnings for the last quarter are 6.01 EUR per share, whereas the estimation was 5.92 EUR resulting in a 1.46% surprise. The estimated earnings for the next quarter are 5.32 EUR per share. See more details about HCA-HEALTHCARE earnings.
HCA-HEALTHCARE revenue for the last quarter amounts to 17.66 B EUR, despite the estimated figure of 17.61 B EUR. In the next quarter, revenue is expected to reach 16.88 B EUR.
4HCA net income for the last quarter is 1.39 B EUR, while the quarter before that showed 1.14 B EUR of net income which accounts for 21.78% change. Track more HCA-HEALTHCARE financial stats to get the full picture.
Yes, 4HCA dividends are paid quarterly. The last dividend per share was 0.66 EUR. As of today, Dividend Yield (TTM)% is 0.81%. Tracking HCA-HEALTHCARE dividends might help you take more informed decisions.
HCA-HEALTHCARE dividend yield was 0.88% in 2024, and payout ratio reached 12.00%. The year before the numbers were 0.89% and 12.66% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 20, 2025, the company has 316 K employees. See our rating of the largest employees — is HCA-HEALTHCARE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HCA-HEALTHCARE EBITDA is 13.39 B EUR, and current EBITDA margin is 19.63%. See more stats in HCA-HEALTHCARE financial statements.
Like other stocks, 4HCA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HCA-HEALTHCARE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HCA-HEALTHCARE technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HCA-HEALTHCARE stock shows the sell signal. See more of HCA-HEALTHCARE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.